Published in Heart Rhythm on November 01, 2005
Recent advances in cardiac resynchronization therapy: echocardiographic modalities, patient selection, optimization, non-responders--all you need to know for more efficient CRT. Int J Cardiovasc Imaging (2009) 1.51
The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial. Eur Heart J (2009) 1.02
A prospective pilot study to evaluate the relationship between acute change in left ventricular synchrony after cardiac resynchronization therapy and patient outcome using a single-injection gated SPECT protocol. Circ Cardiovasc Imaging (2011) 1.00
Optimal use of echocardiography in cardiac resynchronisation therapy. Heart (2007) 0.93
Impact of contractile reserve on acute response to cardiac resynchronization therapy. Cardiovasc Ultrasound (2008) 0.83
Lead positioning strategies to enhance response to cardiac resynchronization therapy. Heart Fail Rev (2011) 0.83
Presence of left ventricular contractile reserve, evaluated by means of dobutamine stress-echo test, is able to predict response to cardiac resynchronization therapy. J Interv Card Electrophysiol (2008) 0.77
Baseline asynchrony, assessed circumferentially using temporal uniformity of strain, besides coincidence between site of latest mechanical activation and presumed left ventricular lead position, predicts favourable prognosis after resynchronization therapy. Int J Cardiovasc Imaging (2011) 0.77
Association between Latest Activated Sites in the Left Ventricle and Akinetic Segments in Patients with Ischemic Cardiomyopathy. J Tehran Heart Cent (2016) 0.75
Dobutamine stress echocardiography and tissue synchronization imaging. Eurasian J Med (2008) 0.75
Acute beneficial hemodynamic effects of a novel 3D-echocardiographic optimization protocol in cardiac resynchronization therapy. PLoS One (2012) 0.75
Assesment of myocardial ischemia by combination of tissue synchronisation imaging and dobutamine stress echocardiography. Korean Circ J (2013) 0.75
Current role of echocardiography in cardiac resynchronization therapy. Heart Fail Rev (2017) 0.75
[Cardiac resynchronization therapy: preoperative screening. How can we reliably predict response to CRT?]. Herzschrittmacherther Elektrophysiol (2009) 0.75
Abnormal diastolic function underlies the different beneficial effects of cardiac resynchronization therapy on ischemic and non-ischemic cardiomyopathy. Clinics (Sao Paulo) (2017) 0.75
Cardiac resynchronization therapy in clinical practice: need for electrical, mechanical, clinical and logistic synchronization. J Interv Card Electrophysiol (2007) 0.75
Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation (2004) 4.04
Mortality reduction by heart rate characteristic monitoring in very low birth weight neonates: a randomized trial. J Pediatr (2011) 3.36
Bundle-branch block morphology and other predictors of outcome after cardiac resynchronization therapy in Medicare patients. Circulation (2010) 3.26
Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3. Circulation (2003) 3.15
The role of methylene blue in serotonin syndrome following cardiac transplantation: a case report and review of the literature. J Thorac Cardiovasc Surg (2012) 2.86
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol (2008) 2.67
Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins. Circulation (2003) 2.67
Heart rate characteristics: novel physiomarkers to predict neonatal infection and death. Pediatrics (2005) 2.60
Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo. Diabetes (2004) 2.55
Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation (2007) 2.40
Heart rate characteristics and laboratory tests in neonatal sepsis. Pediatrics (2005) 2.31
Therapeutic arteriogenesis by ultrasound-mediated VEGF165 plasmid gene delivery to chronically ischemic skeletal muscle. Circ Res (2007) 2.14
Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle. Diabetes (2006) 2.14
Lead extraction in the contemporary setting: the LExICon study: an observational retrospective study of consecutive laser lead extractions. J Am Coll Cardiol (2010) 2.11
Does the Society of Thoracic Surgeons risk score accurately predict operative mortality for patients with pulmonary hypertension? J Thorac Cardiovasc Surg (2012) 2.09
Anemia, apnea of prematurity, and blood transfusions. J Pediatr (2012) 2.08
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol (2012) 2.08
Assessment of endogenous and therapeutic arteriogenesis by contrast ultrasound molecular imaging of integrin expression. Circulation (2005) 2.04
Sudden cardiac death and dialysis patients. Semin Dial (2008) 1.92
Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles. Ultrasound Med Biol (2003) 1.88
Cerebrovascular complication associated with pulmonary vein ablation. J Cardiovasc Electrophysiol (2002) 1.87
Multimodality cardiovascular molecular imaging, Part II. Circ Cardiovasc Imaging (2009) 1.82
Binding and detachment dynamics of microbubbles targeted to P-selectin under controlled shear flow. J Control Release (2004) 1.81
Molecular imaging of the initial inflammatory response in atherosclerosis: implications for early detection of disease. Arterioscler Thromb Vasc Biol (2009) 1.79
Targeted-microbubble binding selectively to GPIIb IIIa receptors of platelet thrombi. Invest Radiol (2002) 1.74
Abnormal heart rate characteristics preceding neonatal sepsis and sepsis-like illness. Pediatr Res (2003) 1.73
Managing superior vena cava syndrome as a complication of pacemaker implantation: a pooled analysis of clinical practice. Pacing Clin Electrophysiol (2009) 1.71
Abnormal skeletal muscle capillary recruitment during exercise in patients with type 2 diabetes mellitus and microvascular complications. J Am Coll Cardiol (2009) 1.71
Molecular imaging of activated von Willebrand factor to detect high-risk atherosclerotic phenotype. JACC Cardiovasc Imaging (2010) 1.71
The role of temporary biventricular pacing in the cardiac surgical patient with severely reduced left ventricular systolic function. J Thorac Cardiovasc Surg (2008) 1.70
Molecular imaging with targeted contrast ultrasound. Curr Opin Biotechnol (2007) 1.70
Ultrasound-mediated vascular gene transfection by cavitation of endothelial-targeted cationic microbubbles. JACC Cardiovasc Imaging (2012) 1.63
A suggested roadmap for cardiovascular ultrasound research for the future. J Am Soc Echocardiogr (2011) 1.60
Image integration using intracardiac ultrasound and 3D reconstruction for scar mapping and ablation of ventricular tachycardia. J Cardiovasc Electrophysiol (2010) 1.56
Heart rate characteristics and clinical signs in neonatal sepsis. Pediatr Res (2007) 1.56
Vascular recruitment in skeletal muscle during exercise and hyperinsulinemia assessed by contrast ultrasound. Am J Physiol Endocrinol Metab (2002) 1.56
Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition. Circ Cardiovasc Imaging (2012) 1.53
Mixed meal and light exercise each recruit muscle capillaries in healthy humans. Am J Physiol Endocrinol Metab (2006) 1.52
Cost and yield of adding electrocardiography to history and physical in screening Division I intercollegiate athletes: a 5-year experience. Heart Rhythm (2010) 1.52
Pressure frequency characteristics of the pericardial space and thorax during subxiphoid access for epicardial ventricular tachycardia ablation. Heart Rhythm (2010) 1.50
Patterns of late gadolinium enhancement in chronic hemodialysis patients. JACC Cardiovasc Imaging (2008) 1.48
Detection of recent myocardial ischaemia by molecular imaging of P-selectin with targeted contrast echocardiography. Eur Heart J (2007) 1.47
2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg (2012) 1.45
Mitral stenosis caused by an amplatzer occluder device used to treat a paravalvular leak. Ann Thorac Surg (2012) 1.39
Phospholemman inhibition of the cardiac Na+/Ca2+ exchanger. Role of phosphorylation. J Biol Chem (2006) 1.39
Deformable gas-filled microbubbles targeted to P-selectin. J Control Release (2006) 1.37
Molecular imaging of endothelial vascular cell adhesion molecule-1 expression and inflammatory cell recruitment during vasculogenesis and ischemia-mediated arteriogenesis. Circulation (2008) 1.35
Targeting mucosal addressin cellular adhesion molecule (MAdCAM)-1 to noninvasively image experimental Crohn's disease. Gastroenterology (2006) 1.35
Sample entropy. Methods Enzymol (2004) 1.35
Noninvasive imaging of myocardial reperfusion injury using leukocyte-targeted contrast echocardiography. Circulation (2002) 1.34
Acute cardiac effects of marathon running. J Appl Physiol (1985) (2010) 1.32
Sample asymmetry analysis of heart rate characteristics with application to neonatal sepsis and systemic inflammatory response syndrome. Pediatr Res (2003) 1.30
Serine 68 of phospholemman is critical in modulation of contractility, [Ca2+]i transients, and Na+/Ca2+ exchange in adult rat cardiac myocytes. Am J Physiol Heart Circ Physiol (2005) 1.30
Abnormal heart rate characteristics are associated with neonatal mortality. Pediatr Res (2004) 1.29
Temporal characterization of the functional density of the vasa vasorum by contrast-enhanced ultrasonography maximum intensity projection imaging. JACC Cardiovasc Imaging (2010) 1.28
Microultrasound molecular imaging of vascular endothelial growth factor receptor 2 in a mouse model of tumor angiogenesis. Mol Imaging (2007) 1.27
Heart rate characteristics monitoring for neonatal sepsis. IEEE Trans Biomed Eng (2006) 1.27
Cardiovascular oscillations at the bedside: early diagnosis of neonatal sepsis using heart rate characteristics monitoring. Physiol Meas (2011) 1.26
A new algorithm for detecting central apnea in neonates. Physiol Meas (2011) 1.26
The vasodilatory actions of insulin on resistance and terminal arterioles and their impact on muscle glucose uptake. Diabetes Metab Res Rev (2004) 1.26
Catheter ablation of atrial fibrillation without fluoroscopy using intracardiac echocardiography and electroanatomic mapping. Circ Arrhythm Electrophysiol (2009) 1.25
Skeletal muscle capillary responses to insulin are abnormal in late-stage diabetes and are restored by angiotensin-converting enzyme inhibition. Am J Physiol Endocrinol Metab (2007) 1.25
Increased nonstationarity of neonatal heart rate before the clinical diagnosis of sepsis. Ann Biomed Eng (2004) 1.24
Identification of an endogenous inhibitor of the cardiac Na+/Ca2+ exchanger, phospholemman. J Biol Chem (2005) 1.23
Hybrid epicardial-endocardial ablation using a pericardioscopic technique for the treatment of atrial fibrillation. Heart Rhythm (2012) 1.23
Contrast echocardiography. Curr Probl Cardiol (2007) 1.22
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am J Gastroenterol (2008) 1.21
Risk of hematoma complications after device implant in the clopidogrel era. Circ Arrhythm Electrophysiol (2010) 1.20
Microbubble-enhanced ultrasound to deliver an antisense oligodeoxynucleotide targeting the human androgen receptor into prostate tumours. J Steroid Biochem Mol Biol (2006) 1.19
Endotoxin depresses heart rate variability in mice: cytokine and steroid effects. Am J Physiol Regul Integr Comp Physiol (2009) 1.19
Placement of transvenous pacemaker and ICD leads across total chronic occlusions. Pacing Clin Electrophysiol (2005) 1.18